Jyong Biotech (MENS)

• Market cap: $157M
• 1 day: -11.3%
• 5 days: -4.93%
• 1 month: 0.95%
• 3 months: 6%
• 6 months: -9.79%
• Year to date: -37.83%
• 1 year: -96.19%
• 5 years: -79.03%
• 10 years: -79.03%
• Sector: Healthcare
• Industry: Biotechnology

About: Jyong Biotech Ltd is research and develop new drugs for today's great unmet medical needs and planned to manufacture and sell new drugs after receiving regulatory approval. It is a science-driven biotechnology company based in Taiwan and are committed to developing and commercializing and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia. The Group operates and manages its business as a single segment in the research and development of novel therapeutics targeting unmet needs. The company's product pipeline includes MCS-2, PCP, IC.

Employees: 27